Announced
Completed
Financials
Sources
Tags
novel topical treatments
development
Pharmaceuticals
United Kingdom
Acquisition
Private
Completed
Single Bidder
Private Equity
Synopsis
Acquisition by Sienna Biopharmaceuticals of Creabilis, a pharmaceutical company focusing on the development of novel topical treatments for common inflammatory skin conditions.
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.